Figure 3 | Scientific Reports

Figure 3

From: Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

Figure 3The alternative text for this image may have been generated using AI.

(A) γ-H2AX antibody staining was performed in formalin-fixed tumor tissue for each group at the completion of treatment. DNA damage was significantly increased in the M3814 + IR group in comparison to vehicle alone (p < 0.01). (B) Micrographs of γ-H2AX antibody staining in each group.

Back to article page